NO179075C - Fremgangsmåte for fremstilling av human lymfotoksin samt antistoff mot dette - Google Patents

Fremgangsmåte for fremstilling av human lymfotoksin samt antistoff mot dette

Info

Publication number
NO179075C
NO179075C NO852173A NO852173A NO179075C NO 179075 C NO179075 C NO 179075C NO 852173 A NO852173 A NO 852173A NO 852173 A NO852173 A NO 852173A NO 179075 C NO179075 C NO 179075C
Authority
NO
Norway
Prior art keywords
antibody
preparation
human lymphotoxin
lymphotoxin
human
Prior art date
Application number
NO852173A
Other languages
English (en)
Norwegian (no)
Other versions
NO179075B (no
NO852173L (no
Inventor
Bharat Bhushan Aggarwal
Timothy Scott Bringman
Patrick William Gray
Glenn Evan Nedwin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/616,502 external-priority patent/US4959457A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO852173L publication Critical patent/NO852173L/no
Publication of NO179075B publication Critical patent/NO179075B/no
Publication of NO179075C publication Critical patent/NO179075C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C07K16/242—Lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C07K14/5255—Lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO852173A 1984-05-31 1985-05-30 Fremgangsmåte for fremstilling av human lymfotoksin samt antistoff mot dette NO179075C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61650384A 1984-05-31 1984-05-31
US06/616,502 US4959457A (en) 1984-05-31 1984-05-31 Anti-lymphotoxin
US73231285A 1985-05-09 1985-05-09

Publications (3)

Publication Number Publication Date
NO852173L NO852173L (no) 1985-12-02
NO179075B NO179075B (no) 1996-04-22
NO179075C true NO179075C (no) 1996-07-31

Family

ID=27417179

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852173A NO179075C (no) 1984-05-31 1985-05-30 Fremgangsmåte for fremstilling av human lymfotoksin samt antistoff mot dette

Country Status (23)

Country Link
EP (2) EP0164965B1 (fa)
JP (3) JP2521703B2 (fa)
AR (1) AR245219A1 (fa)
AT (2) ATE95243T1 (fa)
AU (1) AU599303B2 (fa)
BG (1) BG60256B1 (fa)
CA (1) CA1340641C (fa)
CZ (1) CZ283148B6 (fa)
DE (2) DE3587597T2 (fa)
DK (1) DK171531B1 (fa)
ES (1) ES8802182A1 (fa)
FI (1) FI93025C (fa)
GR (1) GR851317B (fa)
HU (1) HU204085B (fa)
IE (1) IE63487B1 (fa)
IL (1) IL75318A (fa)
NO (1) NO179075C (fa)
NZ (1) NZ212207A (fa)
PL (1) PL155410B1 (fa)
PT (1) PT80573B (fa)
RO (1) RO100383A2 (fa)
SK (1) SK278333B6 (fa)
YU (1) YU47735B (fa)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88175C (fi) 1980-04-03 1993-04-13 Biogen Inc Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
US5683688A (en) 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
IL73883A (en) * 1984-12-20 1990-12-23 Yeda Res & Dev Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
EP0216786B1 (en) * 1984-12-21 1992-03-18 Biogen, Inc. Purification, production and use of tumor necrosis factors
AU603768B2 (en) * 1985-07-04 1990-11-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Lymphotoxin dna, lymphotoxin expression vector, lymphotoxin resistant cell, transformant with lymphotoxin expression vector and process for preparing lymphotoxin
JPS62111928A (ja) * 1985-10-15 1987-05-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン
JPS62195285A (ja) * 1986-02-19 1987-08-28 Kanegafuchi Chem Ind Co Ltd リンホトキシン発現ベクタ−及びそれを用いるリンホトキシンの製造方法
EP0230781B1 (en) * 1985-12-24 1992-07-22 Denki Kagaku Kogyo Kabushiki Kaisha Lymphotoxin gene, method for its production, and lymphotoxin
JP2548204B2 (ja) * 1987-06-27 1996-10-30 電気化学工業株式会社 新生理活性ポリペプチド
US5403725A (en) * 1985-12-24 1995-04-04 Denki Kagaku Kogyo Kabushiki Kaisha Method for production of lymphotoxin (TNFB) in cell line A-C5-8
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
JPS63105680A (ja) * 1986-10-22 1988-05-10 Kanegafuchi Chem Ind Co Ltd ヒト・リンホトキシン発現ベクタ−、該発現ベクタ−による形質転換細胞および該細胞を用いるリンホトキシンの製造方法
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin
US5175268A (en) * 1986-12-24 1992-12-29 Takeda Chemical Industries, Ltd. DNA encoding recombinant human lymphotoxin
FI884798A7 (fi) * 1987-10-28 1989-04-29 Eisai Co Ltd Rekombinantlymfotoxin.
DE3837012A1 (de) * 1988-01-15 1989-07-27 Knoll Ag Verwendung von tnf und lt zur herstellung von arzneimitteln
GB2217326B (en) * 1988-04-08 1991-11-20 British Bio Technology Synthetic gene encoding human tumour necrosis factor beta.
EP0338497A3 (en) * 1988-04-22 1990-05-16 Takeda Chemical Industries, Ltd. Bispecific hybrid monoclonal antibody
JPH023698A (ja) * 1988-06-20 1990-01-09 Denki Kagaku Kogyo Kk ヒトリンホトキシンに対するモノクローナル抗体及びそれら抗体を産生するハイブリドーマ、並びにそれら抗体を用いたヒトリンホトキシンの精製方法、測定方法及び測定試薬
CA2001756A1 (en) * 1988-10-31 1991-04-30 Seiichi Uesugi New human lymphotoxin n-end deletion mutant
JPH03106821A (ja) * 1989-09-20 1991-05-07 Denki Kagaku Kogyo Kk 抗腫瘍剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5747023A (en) * 1994-07-01 1998-05-05 Genentech, Inc. Cancer therapy using lymphotoxin
JP4231106B2 (ja) * 1995-01-23 2009-02-25 ゼノテック インコーポレイティッド 骨溶解および転移を改善する方法
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
US6740739B1 (en) 1998-01-15 2004-05-25 Genentech, Inc. Substitutional variants of APO-2 ligand
EP1572116A4 (en) * 2002-11-26 2007-12-12 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
CA2529945A1 (en) 2003-06-27 2005-01-06 Biogen Idec Ma Inc. Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
WO2005067477A2 (en) * 2003-12-08 2005-07-28 Centocor, Inc. Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
AU2005227322A1 (en) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Receptor coupling agents and therapeutic uses thereof
WO2006074399A2 (en) 2005-01-05 2006-07-13 Biogen Idec Ma Inc. Multispecific binding molecules comprising connecting peptides
KR20090078349A (ko) * 2006-10-12 2009-07-17 제넨테크, 인크. 림포톡신-알파에 대한 항체
JP2010506955A (ja) 2006-10-20 2010-03-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド 可溶性リンホトキシンβレセプターによる脱髄障害の処置
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
EP3134103B1 (en) * 2014-04-25 2020-01-15 Naurex Inc. Stable compositions of neuroactive peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59007A (en) * 1978-12-22 1983-11-30 Biogen Nv Recombinant dna molecules coding for polypeptides displaying hepatitis b virus antigenicity,method of their production and compositions containing the same
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
DE3331108A1 (de) * 1983-08-30 1985-05-02 Boehringer Ingelheim International GmbH, 6507 Ingelheim Verfahren zur herstellung von lymphotoxin und von lymphotoxin-mrna
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
NZ212207A (en) 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin

Also Published As

Publication number Publication date
EP0164965B1 (en) 1993-09-29
AR245219A1 (es) 1993-12-30
ES543695A0 (es) 1988-04-16
NO179075B (no) 1996-04-22
JPH07291995A (ja) 1995-11-07
DE3587597T2 (de) 1994-06-01
YU91985A (en) 1988-12-31
ATE95243T1 (de) 1993-10-15
CA1340641C (en) 1999-07-13
HUT37814A (en) 1986-02-28
RO100383B1 (ro) 1991-03-01
SK393085A3 (en) 1996-11-06
PT80573A (en) 1985-06-01
IE63487B1 (en) 1995-05-03
FI93025C (fi) 1995-02-10
ATE195323T1 (de) 2000-08-15
PT80573B (pt) 1987-08-19
JPS6156197A (ja) 1986-03-20
JP2804237B2 (ja) 1998-09-24
DK171531B1 (da) 1996-12-23
DK241385D0 (da) 1985-05-30
DE3587597D1 (de) 1993-11-04
BG60256B2 (bg) 1994-03-24
EP0509553B1 (en) 2000-08-09
HU204085B (en) 1991-11-28
RO100383A2 (ro) 1991-10-17
NZ212207A (en) 1991-07-26
DE3588225D1 (de) 2000-09-14
CZ283148B6 (cs) 1998-01-14
AU599303B2 (en) 1990-07-19
PL253739A1 (en) 1986-03-11
JPH07250692A (ja) 1995-10-03
PL155410B1 (en) 1991-11-29
IE851321L (en) 1985-11-30
IL75318A (en) 1994-08-26
AU4320385A (en) 1985-12-05
BG60256B1 (bg) 1994-03-24
IE930589L (en) 1985-11-30
SK278333B6 (en) 1996-11-06
YU47735B (sh) 1996-01-08
ES8802182A1 (es) 1988-04-16
FI93025B (fi) 1994-10-31
EP0509553A1 (en) 1992-10-21
FI852143A0 (fi) 1985-05-29
NO852173L (no) 1985-12-02
DK241385A (da) 1985-12-01
EP0164965A3 (en) 1988-04-06
DE3588225T2 (de) 2001-04-05
EP0164965A2 (en) 1985-12-18
JP2521703B2 (ja) 1996-08-07
IL75318A0 (en) 1985-09-29
CZ393085A3 (en) 1997-07-16
GR851317B (fa) 1985-11-25
FI852143L (fi) 1985-12-01

Similar Documents

Publication Publication Date Title
NO179075C (no) Fremgangsmåte for fremstilling av human lymfotoksin samt antistoff mot dette
KR870700299A (ko) 다른물체에 부착시키기 위해 분리가능 패스너를 적합시키기 위한 방법 및 그 장치
NL930141I1 (nl) Csf en werkwijze voor de bereiding hiervan
AU604958B2 (en) Human serum albumin crystals and method of preparation
AU3227684A (en) Detection of antibodies in human serum
IL88375A0 (en) Monoclonal antibodies to interferon-beta 2 and method of purification of interferon-beta 2
FI901487A7 (fi) x-aryylialkaanihappojen valmistus
EP0164977A3 (en) Agglomerates of malachite crystals and method for their preparation
IL72452A0 (en) Method for the preparation of yeast chromatin and its use for obtaining antibodies for the detection of mammalian carcinomas
FI885692L (fi) Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi
FI885721A0 (fi) Makeutusaine ja menetelmä sen valmistamiseksi
DK205986A (da) Proteinhydrolysat samt fremstilling deraf
EP0210029A3 (en) Monoclonal antibodies to human plasma prekallikrein and methods of preparing and using same
EP0269526A3 (en) Method of quantitative determination of antigens and antibodies
ZA872784B (en) Detection of inflammation and novel antibodies therefor
KR860005021A (ko) HBc 항원의 정재방법 및 정제된 HBc 항원을 이용한 HBc 항체의 측정방법
BR8201414A (pt) Composicoes de combustao lenta e metodo de sua preparacao
PT83105A (en) Method for determining the presence of specific ige in human serum
ES546865A0 (es) Metodo de elaboracion de cierres de cremallera separables
FI904681A7 (fi) 5'fosfodiesteraasientsyymin valmistus ja menetelmä sen tuottamiseksi
DK157205C (da) Bjaelke samt fremgangsmaade til fremstilling heraf
JPS6480299A (en) Ligand and method for enhancing propagation of b-cells
ES552665A0 (es) Metodo de elaboracion de cierres de cremallera
GR80228B (en) Method for the preparation of lymphotoxin and lymphotoxin-mrna
ES547745A0 (es) Metodo de elaboracion de cierres de cremallera